Alessandro Giollo

Padova, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 123 publications

Whole-blood coagulation and platelet dynamics identify differential prothrombotic states in patients with rheumatoid arthritis treated with JAK or TNF-ɑ inhibitors.

Whole-blood coagulation and platelet dynamics identify differential prothrombotic states in patients with rheumatoid arthritis treated with JAK or TNF-ɑ inhibitors.

Journal: RMD open

Published: March 18, 2026

Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritis.

Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritis.

Journal: Frontiers in pharmacology

Published: November 29, 2025

Prevalence, incidence, mortality and causes of death in a large cohort of patients with rheumatoid arthritis: an Italian population-based study.

Prevalence, incidence, mortality and causes of death in a large cohort of patients with rheumatoid arthritis: an Italian population-based study.

Journal: RMD open

Published: October 14, 2025

In Reply: Beyond Biology: Unpacking the Physician Sex Effect in Rheumatoid Arthritis Management.

In Reply: Beyond Biology: Unpacking the Physician Sex Effect in Rheumatoid Arthritis Management.

Journal: Mayo Clinic proceedings

Published: September 15, 2025

Safety of JAK inhibitors versus other biologic therapies following anti-TNF failure in patients with rheumatoid arthritis.

Safety of JAK inhibitors versus other biologic therapies following anti-TNF failure in patients with rheumatoid arthritis.

Journal: Arthritis research & therapy

Published: August 27, 2025

Parvovirus B19 infection with rheumatologic manifestations: results from a multicentre Italian study.

Parvovirus B19 infection with rheumatologic manifestations: results from a multicentre Italian study.

Journal: Clinical and experimental rheumatology

Published: August 07, 2025

Relapsing Whipple's disease in patients with severe arthritis.

Relapsing Whipple's disease in patients with severe arthritis.

Journal: Rheumatology (Oxford, England)

Published: June 29, 2025

Primordial and primary prevention in rheumatological diseases: The time has come.

Primordial and primary prevention in rheumatological diseases: The time has come.

Journal: Autoimmunity reviews

Published: May 26, 2025

Do DMARDs increase the risk of cancer recurrence in patients with spondyloarthritis, psoriatic arthritis and rheumatoid arthritis?

Do DMARDs increase the risk of cancer recurrence in patients with spondyloarthritis, psoriatic arthritis and rheumatoid arthritis?

Journal: Clinical and experimental rheumatology

Published: May 22, 2025

MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRY.

MYCOPHENOLATE MOFETIL TREATMENT REDUCES THE RISK OF TREATMENT ESCALATION DUE TO VASCULAR COMPLICATIONS IN LIMITED CUTANEOUS SYSTEMIC SCLEROSIS: EMULATION OF A TARGET TRIAL FROM ITALIAN RHEUMATOLOGY SOCIETY SPRING REGISTRY.

Journal: Arthritis care & research

Published: May 02, 2025

Mycophenolate Mofetil Treatment Reduces the Risk of Treatment Escalation Due to Vascular Complications in Limited Cutaneous Systemic Sclerosis: Emulation of a Target Trial From the Italian Rheumatology Society SPRING Registry.

Mycophenolate Mofetil Treatment Reduces the Risk of Treatment Escalation Due to Vascular Complications in Limited Cutaneous Systemic Sclerosis: Emulation of a Target Trial From the Italian Rheumatology Society SPRING Registry.

Journal: Arthritis care & research

Published: May 02, 2025

Intensive therapeutic plasma exchange in life-threatening ANCA-associated vasculitis.

Intensive therapeutic plasma exchange in life-threatening ANCA-associated vasculitis.

Journal: Rheumatology (Oxford, England)

Published: April 28, 2025

Showing 1-12 of 123

Last Updated: 09/26/2026